BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8747245)

  • 21. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft.
    Dimar JR; Glassman SD; Burkus KJ; Carreon LY
    Spine (Phila Pa 1976); 2006 Oct; 31(22):2534-9; discussion 2540. PubMed ID: 17047540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of recombinant human bone morphogenetic protein 2 (rhBMP-2) to promote spinal fusion in a nonhuman primate anterior interbody fusion model.
    Hecht BP; Fischgrund JS; Herkowitz HN; Penman L; Toth JM; Shirkhoda A
    Spine (Phila Pa 1976); 1999 Apr; 24(7):629-36. PubMed ID: 10209790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early-term and mid-term histologic events during single-level posterolateral intertransverse process fusion with rhBMP-2/collagen carrier and a ceramic bulking agent in a nonhuman primate model: implications for bone graft preparation.
    Khan SN; Toth JM; Gupta K; Glassman SD; Gupta MC
    J Spinal Disord Tech; 2014 Jun; 27(4):212-9. PubMed ID: 23073151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histologic evaluation of the efficacy of rhBMP-2 compared with autograft bone in sheep spinal anterior interbody fusion.
    Sandhu HS; Toth JM; Diwan AD; Seim HB; Kanim LE; Kabo JM; Turner AS
    Spine (Phila Pa 1976); 2002 Mar; 27(6):567-75. PubMed ID: 11884903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of recombinant human bone morphogenetic protein-2 with local bone graft instead of iliac crest bone graft in posterolateral lumbar spine arthrodesis.
    Park DK; Kim SS; Thakur N; Boden SD
    Spine (Phila Pa 1976); 2013 May; 38(12):E738-47. PubMed ID: 23474598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of recombinant human bone morphogenic protein in posterior interbody fusions of the lumbar spine: a clinical series.
    Geibel PT; Boyd DL; Slabisak V
    J Spinal Disord Tech; 2009 Jul; 22(5):315-20. PubMed ID: 19525785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of bone morphogenetic protein-2 for adult spinal deformity.
    Luhmann SJ; Bridwell KH; Cheng I; Imamura T; Lenke LG; Schootman M
    Spine (Phila Pa 1976); 2005 Sep; 30(17 Suppl):S110-7. PubMed ID: 16138058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. rhBMP-6 stimulated osteoprogenitor cells enhance posterolateral spinal fusion in the New Zealand white rabbit.
    Valdes M; Moore DC; Palumbo M; Lucas PR; Robertson A; Appel J; Ehrlich MG; Keeping HS
    Spine J; 2007; 7(3):318-25. PubMed ID: 17482115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1995 Volvo Award in basic sciences. The use of an osteoinductive growth factor for lumbar spinal fusion. Part II: Study of dose, carrier, and species.
    Boden SD; Schimandle JH; Hutton WC
    Spine (Phila Pa 1976); 1995 Dec; 20(24):2633-44. PubMed ID: 8747241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lower dose of rhBMP-2 achieves spine fusion when combined with an osteoconductive bulking agent in non-human primates.
    Barnes B; Boden SD; Louis-Ugbo J; Tomak PR; Park JS; Park MS; Minamide A
    Spine (Phila Pa 1976); 2005 May; 30(10):1127-33. PubMed ID: 15897825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant human bone morphogenetic protein-2 enhances anterior spinal fusion in a thoracoscopically instrumented animal model.
    Sucato DJ; Hedequist D; Zhang H; Pierce WA; O'Brien SE; Welch RD
    J Bone Joint Surg Am; 2004 Apr; 86(4):752-62. PubMed ID: 15069140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Instrumented one and two level posterolateral fusions with recombinant human bone morphogenetic protein-2 and allograft: a computed tomography study.
    Stambough JL; Clouse EK; Stambough JB
    Spine (Phila Pa 1976); 2010 Jan; 35(1):124-9. PubMed ID: 20042965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. rhBMP-2 (ACS and CRM formulations) overcomes pseudarthrosis in a New Zealand white rabbit posterolateral fusion model.
    Lawrence JP; Waked W; Gillon TJ; White AP; Spock CR; Biswas D; Rosenberger P; Troiano N; Albert TJ; Grauer JN
    Spine (Phila Pa 1976); 2007 May; 32(11):1206-13. PubMed ID: 17495777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A porcine collagen-derived matrix as a carrier for recombinant human bone morphogenetic protein-2 enhances spinal fusion in rats.
    Miyazaki M; Morishita Y; He W; Hu M; Sintuu C; Hymanson HJ; Falakassa J; Tsumura H; Wang JC
    Spine J; 2009; 9(1):22-30. PubMed ID: 18805060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular methods of enhancing lumbar spine fusion.
    Sheehan JP; Kallmes DF; Sheehan JM; Jane JA; Fergus AH; diPierro CG; Simmons NE; Makel DD; Helm GA
    Neurosurgery; 1996 Sep; 39(3):548-54. PubMed ID: 8875485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2.
    Burkus JK; Transfeldt EE; Kitchel SH; Watkins RG; Balderston RA
    Spine (Phila Pa 1976); 2002 Nov; 27(21):2396-408. PubMed ID: 12438990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ne-Osteo bone growth factor for posterolateral lumbar spine fusion: results from a nonhuman primate study and a prospective human clinical pilot study.
    Boden SD; Grob D; Damien C
    Spine (Phila Pa 1976); 2004 Mar; 29(5):504-14. PubMed ID: 15129063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morphology of the lumbar intertransverse process fusion mass in the rabbit model: a comparison between two bone graft materials--rhBMP-2 and autograft.
    Holliger EH; Trawick RH; Boden SD; Hutton WC
    J Spinal Disord; 1996 Apr; 9(2):125-8. PubMed ID: 8793779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiographic, biomechanical, and histological evaluation of rhBMP-2 in a 3-level intertransverse process spine fusion: an ovine study.
    Toth JM; Wang M; Lawson J; Badura JM; DuBose KB
    J Neurosurg Spine; 2016 Dec; 25(6):733-739. PubMed ID: 27367941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of coralline hydroxyapatite with bone marrow, autogenous bone graft, or osteoinductive bone protein extract for posterolateral lumbar spine fusion.
    Boden SD; Martin GJ; Morone M; Ugbo JL; Titus L; Hutton WC
    Spine (Phila Pa 1976); 1999 Feb; 24(4):320-7. PubMed ID: 10065514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.